OncoSec Medical Incorporated Gains 88.89%
Wed, Mar 01, 2023 at 07:11 PM
OncoSec Medical Incorporated (ONCS:NASDAQ) rocketted at $2.04, a gain of 88.9%. On Wed, Mar 01, 2023, ONCS:NASDAQ touched a New 2-Week High of $2.04. From Wed, Feb 15, 2023, the stock recorded 33.33% Up Days and 20.00% Green Days
The stock spiked on Wed, Mar 01, 2023 at $2.65 with a volume of 65M+.
About OncoSec Medical Incorporated (ONCS:NASDAQ)
OncoSec Medical Inc is a biotechnology company engaged in designing, developing and commercializing gene therapies, therapeutics and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer.
Top 10 Gainers:
- Reata Pharmaceuticals, Inc. (RETA:NASDAQ), 198.91%
- HPX Corp. Class A (HPX:NYSEMKT), 173.71%
- HPX Corp. Class A (HPX:NYSE), 173.71%
- Cardio Diagnostics Holdings Inc Com (CDIO:NASDAQ), 91.3%
- OncoSec Medical Incorporated (ONCS:NASDAQ), 88.89%
- BiomX Inc. (PHGE:NYSEMKT), 43.31%
- Decarbonization Plus Acquisition Corporation IV (DCRD:NASDAQ), 40.52%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 37.72%
- Mmtec, Inc. (MTC:NASDAQ), 37.39%
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 34.43%